GLP-1 drugs have been compared to the discovery of penicillin, which changed the course of medicine by treating several life-threatening illnesses.

What's behind the obesity epidemic? Conventional wisdom would tell you it's that we don't move enough and we eat too many calories. But a large new international study suggests it's not sedentary ...

Biomea Fusion, Inc. ('Biomea,” 'Biomea Fusion” or the 'Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, today announced the appointment of Julianne Averill to its ...

In the third part of his Pharma Commerce video interview, Hyung Heon Kim, CEO of MetaVia, outlines alternative reimbursement or value-based contracting models that could be feasible in the short term, ...

GLP-1 blockbusters like semaglutide and tirzepatide are widely used for diabetes and weight loss but come with some nasty ...

Thirty-nine percent of millennials and 35% of Gen Z say access to weight loss drugs would improve their job satisfaction or ...

Study reveals primary cause of obesity — and it's not lack of exercise Rene Kirby, “Shallow Hal” actor, dies at 70 after ...

Taxes on Social Security benefits were not eliminated despite what you've heard Study reveals primary cause of obesity — and it's not lack of exercise Rene Kirby, “Shallow Hal” actor, dies at 70 after ...

One explanation for the rise in obesity in industrialized countries is that people burn fewer calories than people in ...

In short, the study shows that eating more calories is a bigger reason for obesity than being less active. But that doesn’t mean physical activity isn’t important. The researchers stress that both ...

A groundbreaking new study has revealed that your DNA may predict whether you’re likely to develop obesity—years before symptoms emerge.

Women and older adults using semaglutide, a popular anti-obesity medication, may face a heightened risk of muscle loss. A recent study suggests that women and older adults who use the weight-loss drug ...